2020
DOI: 10.1016/j.clim.2020.108365
|View full text |Cite
|
Sign up to set email alerts
|

Successful hematopoietic stem cell transplant in leukocyte adhesion deficiency type III presenting primarily as malignant infantile osteopetrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 19 publications
0
9
0
Order By: Relevance
“…6-9 in Table 1 and Figure 1) (43). The deficiency of the b2 integrin subunit of the LFA-1 causes the leukocyte adhesion deficiency (LAD) type I, and the defective activation of LFA-1 subunits has been related to the LAD type III, both nowadays effectively treated with the hematopoietic stem cells transplantation (44,45). On the other side, LAD type II is caused by mutations of a fucose transporter gene leading to cell membrane glycans lacking fucosylation.…”
Section: Activation Defectsmentioning
confidence: 99%
“…6-9 in Table 1 and Figure 1) (43). The deficiency of the b2 integrin subunit of the LFA-1 causes the leukocyte adhesion deficiency (LAD) type I, and the defective activation of LFA-1 subunits has been related to the LAD type III, both nowadays effectively treated with the hematopoietic stem cells transplantation (44,45). On the other side, LAD type II is caused by mutations of a fucose transporter gene leading to cell membrane glycans lacking fucosylation.…”
Section: Activation Defectsmentioning
confidence: 99%
“…The variant screening process was based on disease-related information and variant pathogenicity evaluation (allele frequency in population, in silico tools, ACMG guidelines) ( 23 , 24 ). Genetic disorders that frequently manifest phenotypes similar to our case include juvenile-myelomonocytic-leukemia (JMML) ( 5 , 17 , 25 ) and leukocyte adhesion deficiency (LAD) ( 1 , 26 , 27 ). JMML-related genes include PTPN11 , NRAS , KRAS , NF1 , and CBL .…”
Section: Methodsmentioning
confidence: 54%
“…Specifically, FERMT3 has been widely recognized for its role in cell adhesion, migration, and thrombosis. Several studies have demonstrated that mutations in FERMT3 can lead to leukocyte adhesion deficiency syndrome type 3 (LAD3), resulting in defective platelet function and immunodeficiency [26][27][28]. These findings suggest a potential regulatory role of FERMT3 in the interplay between inflammation and coagulation during the progression of sepsis.…”
Section: Discussionmentioning
confidence: 99%